Fibromyalgia
‘Frightening’ connections between long COVID, fibromyalgia, fatigue warrant more research
SCOTTSDALE, Ariz. — Long COVID, fibromyalgia and chronic fatigue syndrome demonstrate overlapping characteristics that warrant further investigation, according to a speaker at the Basic and Clinical Immunology for the Busy Clinician symposium.
Silo Pharma announces roster of drugs in development for mental health, chronic pain
Silo Pharma will advance a portfolio of four drugs in its 2024 clinical pipeline, targeting conditions related to mental health, chronic pain and neurology.
Patients with rheumatoid arthritis report ‘many symptoms’ of long COVID prior to infection
SAN DIEGO — Patients with rheumatoid arthritis who reported having long COVID in the past year demonstrated “many symptoms” of long COVID prior to initial infection,” according to data presented at ACR Convergence 2023.
Audiovisual-stimulation device improves fibromyalgia symptoms, reduces health care use
An audiovisual-stimulation device improved fibromyalgia symptoms and decreased the use of medications and health care services, according to results of a pilot study presented at PAINWeek.
Celebrating the life of Frederick Wolfe, MD: ‘The consummate physician-scientist’
The rheumatology community is mourning the death of Frederick Wolfe, MD, who contributed invaluably to the world of medical research and was instrumental in classifying fibromyalgia.
Disentangling long COVID from fibromyalgia: Patients often feel ‘disrespected, ignored’
Distinguishing between long COVID and fibromyalgia has challenged health care providers across specialties, but rheumatologists may be positioned to clearly define both conditions and offer patients much-needed relief and respect.
To understand long COVID’s pathogenesis, consider fibromyalgia
The current understanding of long COVID’s pathogenesis may be better served by looking to other diseases and syndromes, particularly fibromyalgia, according to a speaker at the 2023 Biologic Therapies Summit.
Cyclobenzaprine reduces pain, improves sleep quality in patients with fibromyalgia
Patients with fibromyalgia who receive a sublingual tablet form cyclobenzaprine experience reduced daily pain, and improved sleep quality, compared with those who received placebo, according to a press release from the drug’s manufacturer.
Fibromyalgia-related pain may exacerbate opioid addiction
People with opioid use disorder who also had fibromyalgia were more likely to have pain-related exacerbation of their addiction compared with people who had chronic pain without fibromyalgia, findings published in Pain showed.
Fibromyalgia increases odds of worsening pain-related opioid use disorder
Patients with fibromyalgia were at greater risk for pain-related exacerbations of opioid use disorder, according to a study published in Pain.